ArticleThe Journal of veterinary medical science2026
Pathogenicity of a novel orthonairovirus, Iwanai Valley virus, in mice.
Article in The Journal of veterinary medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iwanai Valley virus (IWVV) is a novel tick-borne orthonairovirus classified into the Tamdy genogroup. Since several orthonairoviruses in the Tamdy and closely related Sulina genogroups have been associated with human diseases, evaluating the pathogenic potential of IWVV is an important public health priority. Despite the increase in reports of orthonairoviruses belonging to the Tamdy and Sulina genogroups in East Asia, studies on their pathogenicity remain limited. In this study, we established a mouse model of IWVV infection using type I interferon receptor knockout (IFNAR1-/-) mice and analyzed the pathogenicity of IWVV infection. IWVV infection was lethal in IFNAR1-/-mice but did not cause any significant symptoms in BALB/c mice. IWVV replicated well in the liver and spleen of IFNAR1-/-mice, leading to acute necrotizing hepatitis and damage to the spleen, characterized by lymphocyte depletion. These pathological features are consistent with those observed in immunocompromised mice infected with other human-pathogenic orthonairoviruses, such as Crimean-Congo hemorrhagic fever virus and Yezo virus. Although human infections with IWVV have not been reported, the observed virulence in animal models suggests that further evaluation of its zoonotic potential is warranted. Our findings highlight the importance of continued surveillance of emerging tick-borne IWVV to assess potential risks to public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.